You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Molecular diagnostics firm Evogen and biopharmaceutical company UCB said today that they are collaborating on the development of a proteomics-based diagnostic for the identification of epileptic seizures.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.